TY - JOUR
T1 - Pregnancy following gastric bypass surgery for morbid obesity
AU - Gurewitsch, Edith D.
AU - Smith-Levitin, Michelle
AU - Mack, Judith
PY - 1996/10
Y1 - 1996/10
N2 - Background: Surgical treatment for severe obesity is sometimes recommended. Many long-term risks, particularly to adolescents and to subsequent pregnancies, are still being determined. Case: A 23-year-old woman, gravida 6, para 2, treated for morbid obesity during adolescence with gastric bypass surgery, presented at 6 weeks' gestation with severe microcytic anemia. Significant iron and cobalamin deficiencies were found. Although the vitamin B12 deficiency responded to parenteral treatment, the iron deficiency was refractory to oral supplementation because of malabsorption. By 30 weeks' gestation, the patient required blood transfusions to correct the progressive anemia. Subsequently, she delivered a healthy male infant at term. Conclusion: Severe iron deficiency anemia resulting from malabsorption can complicate pregnancy following gastric bypass surgery for morbid obesity. For women of childbearing age, this potential adverse effect must be considered.
AB - Background: Surgical treatment for severe obesity is sometimes recommended. Many long-term risks, particularly to adolescents and to subsequent pregnancies, are still being determined. Case: A 23-year-old woman, gravida 6, para 2, treated for morbid obesity during adolescence with gastric bypass surgery, presented at 6 weeks' gestation with severe microcytic anemia. Significant iron and cobalamin deficiencies were found. Although the vitamin B12 deficiency responded to parenteral treatment, the iron deficiency was refractory to oral supplementation because of malabsorption. By 30 weeks' gestation, the patient required blood transfusions to correct the progressive anemia. Subsequently, she delivered a healthy male infant at term. Conclusion: Severe iron deficiency anemia resulting from malabsorption can complicate pregnancy following gastric bypass surgery for morbid obesity. For women of childbearing age, this potential adverse effect must be considered.
UR - http://www.scopus.com/inward/record.url?scp=0029740988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029740988&partnerID=8YFLogxK
U2 - 10.1016/0029-7844(96)00187-1
DO - 10.1016/0029-7844(96)00187-1
M3 - Article
C2 - 8841242
AN - SCOPUS:0029740988
SN - 0029-7844
VL - 88
SP - 658
EP - 661
JO - Obstetrics and gynecology
JF - Obstetrics and gynecology
IS - 4 II SUPPL.
ER -